MetabolismNews.net

Metabolism Xagena

Search results for "Bone mineral density"

Fetal programming and childhood factors have been associated with serious adult health risks, such as obesity, heart disease, and cancer. The researchers monitored the health of 171 men and 218 wom ...


Researchers at Johns Hopkins have determined that for subjects aged 55 to 75 years, a moderate program of physical exercise generally maintains bone mass and, in some cases, offers modest improvements ...


The data of the phase III study, MOBILE, confirm Bonviva a once-monthly oral treatment for postmenopausal osteoporosis, is highly effective and well tolerated over two years. Bonviva ( Ibandronic ...


A study has found that intake of magnesium through diet and supplements is positively associated with bone density throughout the whole body, particularly in older white adults. Researchers say the e ...


Twice-yearly subcutaneous injections of Denosumab ( 60 mg; Prolia ) increased bone mineral density ( BMD ) in the lumbar spine, total hip, distal 1/3 radius and total body compared to placebo at 24 mo ...


A study has found that men with low estrogen levels have an increased risk for future hip fracture, and those with both low estrogen and low testosterone levels have the greatest risk. The study, ...


Independent studies of patients in Belgium, Canada, and Germany confirm that there is a major gap in treating patients with osteoporosis, despite the availability of a wide range of drugs, supplements ...


Osteoporosis will affect one in three women over 50 and one in five men over 50. And as the elderly population grows worldwide, by 2050 the number of women and men that will suffer from osteoporosis- ...


Researchers found patients with glucocorticoid-induced osteoporosis who were treated with Teriparatide ( Forteo, Forsteo ) for 36 months had a greater increase in bone mineral density ( BMD ) and fewe ...


Patients who take glucocorticoid drugs ( such as Prednisolone or Prednisone ) to treat a variety of inflammatory/immune-mediated diseases ( such as rheumatoid arthritis or asthma ) can suffer side eff ...


La Food and Drug Administration ( FDA ) has approved a new indication for Prolia ( Denosumab ) as a treatment to increase bone mass in men with osteoporosis at high risk for fracture. Prolia, the firs ...


The results from a phase II trial for Odanacatib, a cathepsin K ( cat-K ) inhibitor in development for the treatment of osteoporosis in post-menopausal women, were presented at the 34th Annual Meeting ...


New data have shown that Forteo ( Teriparatide; Forsteo ) significantly increased lumbar spine volumetric bone mineral density ( vBMD ) compared to Risedronate ( Actonel ) in men with glucocorticoid-i ...


The results from a phase 2 trial evaluating Romosozumab in postmenopausal women with low bone mineral density ( BMD ) were published in the New England Journal of Medicine ( NEJM ).The trial demonstra ...


Two clinical studies were conducted to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and potential immunogenicity of single and multiple escalating doses ( IV [ intravenous ] an ...